Asia Regenerative Medicine

Shenzhen-based bioartificial organ developer, Asia Regenerative Medicine, has reportedly raised tens of millions of renminbi in a pre-Series A financing round. The round was led by Dee Capital, with additional investments from West Lake Photonics, HWealth Capital, Topology Capital, Xiamen Gaoxin Kechuang Angel Venture Capital Co., Ltd, and Ke Xi…